#esophageal — Public Fediverse posts

The journal "Best Practice & Research Clinical Gastroenterology" has dedicated an entire issue toward research on the secondary prevention of esophageal and other upper GI cancers. These review articles include such topics as artificial intelligence (AI), risk-based screening and cost effectiveness.
https://www.esocan.org/screening-and-early-diagnosis-of-upper-gi-neoplastic-lesions-dedicated-journal-issue/
#esophageal #cancer #prevention #resear

This multinational study describes the development and validation of a diagnostic tool (EMERALD) -- a miRNA panel designed to differentiate persons with (or at risk of) #esophageal adenocarcinoma, from non-disease controls. The diagnostic potential of the panel was assessed using #machineLearning models. The findings suggest that it could serve as a #liquidBiopsy and facilitate screening in high-risk persons.
#cancer #epidemiology #screening #cancerPrevention
https://www.esocan.org/liquid-biopsy-to-diagnose-esophageal-adenocarcinoma/

This multinational study describes the development and validation of a diagnostic tool (EMERALD) -- a miRNA panel designed to differentiate persons with (or at risk of) #esophageal adenocarcinoma, from non-disease controls. The diagnostic potential of the panel was assessed using #machineLearning models. The findings suggest that it could serve as a #liquidBiopsy and facilitate screening in high-risk persons.
#cancer #epidemiology #screening #cancerPrevention
https://www.esocan.org/liquid-biopsy-to-diagnose-esophageal-adenocarcinoma/

This multinational study describes the development and validation of a diagnostic tool (EMERALD) -- a miRNA panel designed to differentiate persons with (or at risk of) #esophageal adenocarcinoma, from non-disease controls. The diagnostic potential of the panel was assessed using #machineLearning models. The findings suggest that it could serve as a #liquidBiopsy and facilitate screening in high-risk persons.
#cancer #epidemiology #screening #cancerPrevention
https://www.esocan.org/liquid-biopsy-to-diagnose-esophageal-adenocarcinoma/

This multinational study describes the development and validation of a diagnostic tool (EMERALD) -- a miRNA panel designed to differentiate persons with (or at risk of) #esophageal adenocarcinoma, from non-disease controls. The diagnostic potential of the panel was assessed using #machineLearning models. The findings suggest that it could serve as a #liquidBiopsy and facilitate screening in high-risk persons.
#cancer #epidemiology #screening #cancerPrevention
https://www.esocan.org/liquid-biopsy-to-diagnose-esophageal-adenocarcinoma/

This multinational study describes the development and validation of a diagnostic tool (EMERALD) -- a miRNA panel designed to differentiate persons with (or at risk of) #esophageal adenocarcinoma, from non-disease controls. The diagnostic potential of the panel was assessed using #machineLearning models. The findings suggest that it could serve as a #liquidBiopsy and facilitate screening in high-risk persons.
#cancer #epidemiology #screening #cancerPrevention
https://www.esocan.org/liquid-biopsy-to-diagnose-esophageal-adenocarcinoma/

Several studies suggest that bariatric surgery may lower risk of obesity-related cancers, but it's role in #prevention of #esophageal #cancer is less clear. A multinational Scandanavian study observed that gastric bypass surgery was associated with a decreased risk of esophageal #adenocarcinoma over time after surgery, compared to both the background population and non-operated individuals with morbid obesity.

https://www.esocan.org/gastric-bypass-surgery-associated-with-reduced-risk-of-esophageal-adenocarcinoma/

#research #epidemiology

Radio frequency ablation (RFA) has become a standard of care for persons with advanced dysplasia in Barrett's, but little is known regarding the occurrence and predictors of post-procedure symptoms. This study found that RFA treatment caused considerable post-procedural symptoms of significant duration in the vast majority of patients, with almost all patients experiencing pain and dysphagia after the procedure.

https://www.esocan.org/post-rfa-symptoms/

#epidemiology #cancer #esophageal #esophagus #Barretts

High 1-year #mortality in older patients with #esophageal #cancer: 36% in our study. 23% discontinued #treatment. #Comorbidity and dependency predicted discontinuation.

❗️ #Geriatric assessment helps decision making

🌐 https://t.co/6Glg4uWmSb
#geriatrics #oncology #geriONC #medmastodon